Universal Health Services (NYSE:UHS) received a $137.00 target price from analysts at Mizuho in a report released on Wednesday. The brokerage presently has a “buy” rating on the health services provider’s stock. Mizuho’s price objective indicates a potential upside of 16.11% from the company’s current price.
UHS has been the subject of several other research reports. Zacks Investment Research cut shares of Universal Health Services from a “hold” rating to a “sell” rating in a research note on Saturday, January 6th. Citigroup upgraded shares of Universal Health Services from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Stephens initiated coverage on shares of Universal Health Services in a research note on Wednesday, October 11th. They issued an “equal weight” rating and a $120.00 target price for the company. Goldman Sachs Group initiated coverage on shares of Universal Health Services in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $137.00 target price for the company. Finally, Robert W. Baird reiterated a “buy” rating and issued a $122.00 target price on shares of Universal Health Services in a research note on Friday, October 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Universal Health Services presently has a consensus rating of “Buy” and an average target price of $130.43.
Universal Health Services (UHS) traded up $0.74 during mid-day trading on Wednesday, reaching $117.99. 679,526 shares of the company’s stock were exchanged, compared to its average volume of 957,850. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.26 and a quick ratio of 1.16. Universal Health Services has a one year low of $95.26 and a one year high of $129.74. The company has a market capitalization of $11,200.00, a PE ratio of 16.23, a price-to-earnings-growth ratio of 2.43 and a beta of 0.97.
Universal Health Services declared that its board has initiated a stock buyback program on Wednesday, November 15th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the health services provider to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s leadership believes its stock is undervalued.
A number of large investors have recently bought and sold shares of UHS. Cerebellum GP LLC acquired a new position in Universal Health Services in the fourth quarter worth about $127,000. Crossmark Global Holdings Inc. acquired a new position in Universal Health Services in the third quarter worth about $205,000. Advisor Group Inc. raised its position in Universal Health Services by 198.0% in the second quarter. Advisor Group Inc. now owns 1,812 shares of the health services provider’s stock worth $220,000 after purchasing an additional 1,204 shares in the last quarter. Zeke Capital Advisors LLC acquired a new position in Universal Health Services in the third quarter worth about $228,000. Finally, Veritable L.P. raised its position in Universal Health Services by 16.6% in the second quarter. Veritable L.P. now owns 1,925 shares of the health services provider’s stock worth $235,000 after purchasing an additional 274 shares in the last quarter. 86.26% of the stock is owned by hedge funds and other institutional investors.
Universal Health Services Company Profile
Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.
